Sonas Pharma is a preclinical biotechnology company focused on developing best-in-class, nextgeneration endocannabinoid system modulators for highburden metabolic and neurological disorders. By combining validated human biology with precision pharmacology, Sonas aims to bring forward differentiated small molecules designed to be both effective and safe.